세계의 투약 관리 시스템(MMS) 시장 : 인사이트, 경쟁 환경, 시장 예측(-2032년)

Medication Management System (MMS) Market by Product (Hardware and Software), Application (Prescription & Dispensing Management, Medication Adherence Monitoring, Inventory Management, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of chronic diseases and rising number of medication errors

The Medication Management System (MMS) market was valued at USD 3,455.66 million in 2024, growing at a CAGR of 11.20% during the forecast period from 2022 to 2032 to reach USD 8,051.07 million by 2032. The demand for medication management systems is being driven by the increasing prevalence of chronic diseases, which necessitate prolonged hospital admissions and ongoing treatment. The rising incidence of medication errors and the growing emphasis on improving medication adherence among patients further fuel the demand for these systems. Additionally, the increasing R&D activities, product launches by key players, heightened focus on patient safety, and the need to deliver more effective care are creating significant demand for medication management systems. These factors collectively contribute to the robust growth of the medication management system market, with strong projections from 2022 to 2032.

Medication Management System Market Dynamics:

The growing prevalence of chronic diseases is expected to drive significant market growth for medication management systems. According to GLOBOCAN data from 2023, approximately 20 million new cancer cases were reported in 2022, with this number projected to rise to 32.6 million by 2045. Cancer treatments often involve complex regimens, including chemotherapy, that require precise dosing and timing. A medication management system ensures that medications are administered accurately, and at the correct dosage and intervals, significantly reducing the risk of medication errors.

According to data published by the British Heart Foundation in September 2024, approximately 640 million people globally were affected by heart and circulatory diseases, with these numbers anticipated to rise in the coming years. The same source further stated that around 67 million individuals are diagnosed with heart or circulatory diseases each year, highlighting a growing market opportunity and demand for innovative medication adherence solutions for long-term care.

Similarly, the global diabetes burden is rising rapidly. The International Diabetes Federation reported in 2023 that 537 million adults aged 20-79 were living with diabetes in 2021, a number expected to increase to 643 million by 2030 and 783 million by 2045. Medication management solutions play a critical role in managing insulin dosing by adjusting doses based on real-time blood glucose levels, thereby supporting optimal glucose control and improving patient outcomes. Such increasing cases of chronic disease is driving the market growth.

The growing trend towards improved medication adherence is a key driver for the market growth of medication management systems. According to the National Institute of Health (NIH) in 2023, it was estimated that as many as 50% of patients worldwide fail to follow their prescribed medication regimens. Similarly, data from the Community Research and Development Information Service (CORDIS) in June 2024 highlighted that patient non-adherence is a widespread issue in Europe, with 30-50% of prescribed medications not being taken as directed. Medication non-adherence leads to increased hospitalizations, disease progression, and higher healthcare costs. Medication management systems help address this by providing reminders, alerts, and tracking tools to ensure timely drug administration.

The rising incidence of medication errors is significantly driving the demand for medication management solutions, thereby fueling market growth. According to the World Health Organization (WHO) in September 2023, medication errors impact 1 in every 30 patients in healthcare settings, with over 25% of these errors being severe or life-threatening. Globally, medication errors are estimated to cost healthcare systems a staggering USD 42 billion annually. These alarming statistics underscore the urgent need for effective medication management systems to minimize errors, improve patient safety, and reduce healthcare costs, driving the growth of the medication management systems market.

Additionally, research partnerships and collaborations among key players is further propelling the market growth. For instance, in May 2024, VirtualHealth announced a strategic partnership with MDI Health Technologies (MDI Health). This collaboration leverages MDI Health's innovative technology to transform medication management, enabling leading payors and value-based care providers to optimize treatment strategies, reduce healthcare costs, and enhance clinical outcomes. By harnessing the power of artificial intelligence, this partnership aimed to drive more efficient, effective, and patient-centered care, paving the way for improved healthcare delivery and long-term value in the industry.

However, key challenges such as data privacy and security concerns, as well as the complexity and high implementation costs associated with these systems, are significant barriers that could potentially hinder the growth of the medication management systems market.

Medication Management System Market Segment Analysis:

Medication Management System Market by Product (Hardware and Software), Application (Prescription & Dispensing Management, Medication Adherence Monitoring, Inventory Management, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the medication management system market, the prescription & dispensing management category is estimated to amass a significant revenue share in the medication management system market in 2024. The increasing prevalence of medication errors, coupled with the numerous advantages of medication management systems in the prescription and dispensing processes, is significantly driving the growth of this market segment. According to the Health Services Safety Investigations Body (HSSIB), an estimated 237 million medication errors occur annually at various stages of the medication process in England alone. Similarly, data from the Australian Commission on Safety and Quality in Health Care in 2024 revealed that medication-related issues were responsible for 250,000 hospital admissions in Australia in 2021, incurring a staggering annual cost of USD 1.4 billion. These alarming statistics reflect a growing global challenge that is pushing healthcare systems worldwide to adopt advanced solutions such as prescription and dispensing management systems.

As medication errors continue to rise in various regions, the demand for automated medication management systems becomes even more critical. These systems are designed to eliminate human error in the medication process, ensuring that the correct drugs are dispensed at the right time and in proper dosages. By automating the prescription and dispensing workflows, these systems significantly reduce administrative burdens on healthcare providers and pharmacists, allowing them to allocate more time to patient care rather than time-consuming manual tasks.

Further, product launches in prescription and dispensing management are driving the market growth. For instance, in July 2024, Intelliguard launched Mira Ecosystem, a set of products in medication management that includes Mira IntelligenceTM, Mira PrepTM, Mira CareTM, and Mira SupplyTM. The ecosystem delivers real-time item-level tracking, interoperable data, and streamlined workflows for enhanced efficiency and accuracy. Mira Prep(TM) uses RFID automation to quickly identify medications, eliminating manual processes and reducing preparation time. Mira Care(TM) is a medication-dispensing workstation that provides real-time data, intuitive workflows, and seamless tracking of controlled substances, ensuring timely access to the right medications while allowing providers to focus on patient care.

North America is expected to dominate the overall medication management system market:

North America is expected to dominate the medication management system market, capturing the largest market share globally in 2024. This growth is driven by several key factors, including the rising prevalence of chronic diseases and the growing need for improved medication adherence. As chronic conditions such as diabetes, cardiovascular diseases, and respiratory illnesses continue to increase, the demand for effective medication management solutions is intensifying. The region is also witnessing a rise in medication errors coupled with an increasing emphasis on patient safety, which is further fueling market expansion. Additionally, the market is being propelled by ongoing product development and innovation from leading players in the region are key factors contributing to the growth of the medication management system market in North America.

As per data from GLOBOCAN in 2024, the estimated number of new cancer cases increased from 2,673,174 in 2022 and this number is expected to increase to 3,828,805 by 2045 in North America. Similarly, data cited by the American Cancer Society in 2024, an estimated 2,001,140 new cancer cases were expected to occur in 2024 in the United States.

According to recent data from the Centers for Disease Control and Prevention (CDC) in 2024, approximately 4.9% of adults in the United States were diagnosed with coronary heart disease (CHD) in 2022. Furthermore, physician offices across the country reported about 13 million annual visits related to coronary atherosclerosis and chronic ischemic heart disease.

An article published by the Centers for Disease Control and Prevention (CDC) in May 2024 revealed that approximately 1.2 million individuals aged 18 or older were living with diabetes in the United States in 2021.

According to the Asthma and Allergy Foundation of America in 2022, in the United States, asthma was a significant health concern affecting over 22 million adults aged 18 and older. A medication management system helps to reduce medication errors and enhance adherence to medication at the right time and right administration. These factors are crucial in the treatment of chronic disease, thereby driving the market growth in the region.

The rising need for medication adherence is further driving the market growth in the region. According to data from the Centers for Disease Control and Prevention (CDC) in June 2023, 8.2% of adults aged 18 to 64 years in the U.S. who took prescription medication in the past year reported not adhering to their prescribed regimen in 2021. Medication management systems play a crucial role in improving medication adherence by ensuring patients take their medications as prescribed. This enhanced adherence, in turn, is a key driver of market growth for medication management systems.

Such examples of medication adherence issues are driving key players to develop innovative solutions that enhance patient compliance. For example, in June 2024, PatchRx launched PatchRx Connect, a seamless tool designed to integrate medication adherence data directly into the medication management solution. This solution enables clinical teams to gain real-time insights into patients' medication-taking behaviors, all without disrupting existing workflows or affecting the patient experience. By providing timely, actionable data, PatchRx Connect improves care coordination and boosts medication adherence. Such product developments are accelerating the growth of the medication management system market in the region.

Overall, the combination of the high burden of chronic diseases, the growing focus on medication adherence, the push for enhanced patient safety, and continuous advancements in technology are key factors accelerating the growth of the medication management system market in North America.

Medication Management System Market Key Players:

Some of the key market players operating in the medication management system market include McKesson Corporation, GE HealthCare, BD, Omnicell, Inc., RedSail Technologies, LLC, BestRx, Capsa Healthcare, STOCKART, CareMeds Ltd., Swisslog Healthcare, Bluesight, Ubie Inc., ARxIUM, A-S Medication Solutions, DrFirst, Medical Information Technology, Inc., WellSky, Orion Health, Deenova S.r.l., Dedalus S.p.A., and others.

Recent Developmental Activities in the Medication Management System Market:

• In September 2024, Deenova announced the successful implementation of its closed-loop medication management (CLMM) system at Marien Hospital Gelsenkirchen in Germany. This cutting-edge system combines advanced robotics and software to automate the precise distribution of medication doses, even accommodating last-minute changes prescribed by physicians. By scanning patient wristbands and QR codes on unit dose medications, the CLMM system ensures a seamless and error-free drug administration process.
• In August 2020, Intelliguard, a company in medication management and data intelligence solutions, announced a groundbreaking partnership with Cencora. This collaboration aimed to revolutionize the medication supply chain by providing pre-tagged medications directly to hospitals. The partnership also represents a significant step forward in the widespread adoption of medication management, enhancing efficiency, accuracy, and patient safety across healthcare settings.

Key Takeaways from the Medication Management System Market Report Study

• Market size analysis for current Medication Management System Market size (2024), and market forecast for 8 years (2022 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the Medication Management System market.
• Various opportunities available for the other competitors in the Medication Management System Market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current Medication Management System market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Medication Management System market growth in the coming future?

Target Audience who can be benefited from this Medication Management System Market Report Study

• Medication Management System product providers
• Research organizations and consulting companies
• Medication Management System related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Medication Management System
• Various end-users who want to know more about the Medication Management System Market and the latest technological developments in the Medication Management System Market.

Frequently Asked Questions for the Medication Management System Market:

1. What are Medication Management Systems?

• A medication management system is a comprehensive healthcare solution designed to streamline and optimize the entire medication process, from prescription and dispensing to administration and monitoring. It integrates technology, workflows, and data to ensure the safe, accurate, and efficient use of medications across healthcare settings.

2. What is the market for Medication Management System?

• The Medication Management System (MMS) market was valued at USD 3,455.66 million in 2024, growing at a CAGR of 11.20% during the forecast period from 2022 to 2032 to reach USD 8,051.07 million by 2032.

3. What are the drivers for the Medication Management System market?

• The medication management system market is expected to witness prosperity owing to factors such as the increasing prevalence of chronic diseases. The rising incidence of medication errors and the growing emphasis on improving medication adherence among patients are further fuelling the demand for these systems. Additionally, the increasing R&D activities and product launches by key players along with a heightened focus on patient safety and the need to deliver more effective care. These factors collectively contribute to the robust growth of the medication management system market, with strong projections for the period from 2022 to 2032.

4. Who are the key players operating in the Medication Management System market?

• Some of the key market players operating in the medication management system market include McKesson Corporation, GE HealthCare, BD, Omnicell, Inc., RedSail Technologies, LLC, BestRx, Capsa Healthcare, STOCKART, CareMeds Ltd., Swisslog Healthcare, Bluesight, Ubie Inc., ARxIUM, A-S Medication Solutions, DrFirst, Medical Information Technology, Inc., WellSky, Orion Health, Deenova S.r.l., Dedalus S.p.A., and others.

5. Which region has the highest share in the Medication Management System market?

• North America is expected to dominate the medication management system market, capturing the largest market share globally in 2024. This growth is attributed to the rising prevalence of chronic diseases and the growing need for improved medication adherence. The region is also witnessing a rise in medication errors coupled with an increasing emphasis on patient safety, which is further fuelling market expansion. Additionally, the ongoing product development and innovation from leading players in the region are the key factors contributing to the growth of the medication management system market in North America.

Table of Contents

1. Medication Management System Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Medication Management System Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Medication Management System Market Key Factors Analysis

• 5.1. Medication Management System Market Drivers
  • 5.1.1. The increasing prevalence of chronic diseases
  • 5.1.2. The rising incidence of medication errors
  • 5.1.3. The growing emphasis on improving medication adherence
  • 5.1.4. Increasing R&D activities and product launches by key players
• 5.2. Medication Management System Market Restraints and Challenges
  • 5.2.1. Data privacy and security concerns
  • 5.2.2. Complexity and high implementation costs associated with these systems
• 5.3. Medication Management System Market Opportunity
  • 5.3.1. Integration of advanced technologies such as artificial intelligence (AI), and blockchain, among others
  • 5.3.2. Growing emphasis on digital health solutions to track patient records

6. Medication Management System Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Medication Management System Market Assessment

• 7.1. By Product
  • 7.1.1. Hardware
  • 7.1.2. Software
• 7.2. By Application
  • 7.2.1. Prescription & Dispensing Management
  • 7.2.2. Medication Adherence Monitoring
  • 7.2.3. Inventory Management
  • 7.2.4. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Medication Management System Market Size in USD million (2022-2032)
    • 7.3.1.2. Canada Medication Management System Market Size in USD million (2022-2032)
    • 7.3.1.3. Mexico Medication Management System Market Size in USD million (2022-2032)
  • 7.3.2. Europe
    • 7.3.2.1. France Medication Management System Market Size in USD million (2022-2032)
    • 7.3.2.2. Germany Medication Management System Market Size in USD million (2022-2032)
    • 7.3.2.3. United Kingdom Medication Management System Market Size in USD million (2022-2032)
    • 7.3.2.4. Italy Medication Management System Market Size in USD million (2022-2032)
    • 7.3.2.5. Spain Medication Management System Market Size in USD million (2022-2032)
    • 7.3.2.6. Rest of Europe Medication Management System Market Size in USD million (2022-2032)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Medication Management System Market Size in USD million (2022-2032)
    • 7.3.3.2. Japan Medication Management System Market Size in USD million (2022-2032)
    • 7.3.3.3. India Medication Management System Market Size in USD million (2022-2032)
    • 7.3.3.4. Australia Medication Management System Market Size in USD million (2022-2032)
    • 7.3.3.5. South Korea Medication Management System Market Size in USD million (2022-2032)
    • 7.3.3.6. Rest of Asia-Pacific Medication Management System Market Size in USD million (2022-2032)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Medication Management System Market Size in USD million (2022-2032)
    • 7.3.4.2. Africa Medication Management System Market Size in USD million (2022-2032)
    • 7.3.4.3. South America Medication Management System Market Size In USD Million (2022-2032)

8. Medication Management System Market Company and Product Profiles

• 8.1. McKesson Corporation
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. GE HealthCare
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. BD
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Omnicell, Inc.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. RedSail Technologies, LLC
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. BestRX
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Capsa Healthcare
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. STOCKART
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. CareMeds Ltd
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Swisslog Healthcare
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Bluesight
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Ubie Inc.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. ARxIUM
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. A-S Medication Solutions
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. DrFirst
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Medical Information Technology, Inc.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. WellSky
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Orion Health
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Deenova S.r.l.
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Dedalus S.p.A.
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us